There is no 'getting better' with PSP.
In September 2023, Virginia Representative Jennifer Wexton announced she would not seek reelection after doctors revised her earlier Parkinson's diagnosis to progressive supranuclear palsy — a rare, incurable neurological disease with no effective treatment and a life expectancy of five to seven years post-diagnosis. At 55, she faced a condition that erodes balance, speech, cognition, and movement without mercy or remedy. Her decision to step aside was not a surrender but an act of clear-eyed reckoning, arriving at a moment when the American body politic was already wrestling with the question of what it asks of those who govern while their own bodies are in decline.
- A corrected diagnosis transformed what seemed manageable into something irreversible — PSP is not Parkinson's, and the distinction carries the weight of years.
- With no disease-modifying treatment available and a typical survival window of five to seven years, Wexton confronted a condition that medicine cannot slow, only witness.
- Her announcement landed inside a larger national unease, as voters watched Senator Feinstein appear confused on the Senate floor and Senator McConnell freeze twice before cameras in a matter of weeks.
- Wexton chose to name the reality plainly — 'there is no getting better with PSP' — refusing the political instinct to soften or delay an uncomfortable truth.
- She will finish her current term but will not run again, drawing a line between duty she can still honor and a future the disease will increasingly govern.
On a Monday in September, Representative Jennifer Wexton of Virginia told the public she would not seek reelection. The reason was a diagnosis she described with unsparing honesty as "Parkinson's on steroids" — progressive supranuclear palsy, a rare neurological disease that affects only five in every 100,000 people.
Wexton, 55, had first disclosed a Parkinson's diagnosis in April and had continued working through treatment and therapy. But her doctors later revised their assessment to PSP, a far more serious condition. PSP degrades balance, coordination, speech, swallowing, and eye movement. Unlike Parkinson's, it has no medication that can slow its progression. The typical life expectancy after diagnosis is five to seven years. Roughly 20,000 Americans are believed to have it — a prevalence comparable to ALS, but far less known.
Her announcement arrived during a fraught season in American political life. Senator Dianne Feinstein had already said she would not seek reelection following multiple medical episodes. Senator Mitch McConnell had frozen twice before reporters within weeks and insisted he would stay. Polls reflected growing public anxiety about President Biden's age. Against that backdrop, Wexton's decision to step aside carried meaning beyond her own circumstances.
She had built a consequential career — a lawyer turned state senator, then a congresswoman who flipped Loudoun County from Republican to Democratic control in 2018 after four decades. She had been married 22 years and had two sons.
In her statement, she did not reach for comfort. "There is no 'getting better' with PSP," she said. She would serve out her term, but she would not ask voters to send her back to a job whose demands — the travel, the stamina, the relentless cognitive weight — were no longer compatible with what lay ahead.
On a Monday in September, Representative Jennifer Wexton of Virginia announced she would not seek reelection to Congress. The reason was a diagnosis she had received months earlier—progressive supranuclear palsy, a rare degenerative brain disorder that she described with blunt clarity as "Parkinson's on steroids."
Wexton, 55, had first announced in April that she carried a Parkinson's diagnosis. She had been managing the condition through treatment and therapy, continuing her work on Capitol Hill while navigating its demands. But in the months that followed, her doctors revised their assessment. The new diagnosis was far more serious. Progressive supranuclear palsy, or PSP, is a neurological disease that strikes only five in every 100,000 people. It attacks the brain's ability to control balance and coordination. It degrades speech and swallowing. It impairs eye movement and cognitive function. Unlike Parkinson's, for which treatments exist that can slow progression, there is no medication that effectively halts or slows PSP's advance. The typical life expectancy after diagnosis is five to seven years.
The disease emerges from a gradual deterioration of brain cells across multiple regions of the brain. It strikes men slightly more often than women, but otherwise shows no pattern—no connection to geography, race, occupation, or any other demographic factor that researchers have identified. Roughly 20,000 Americans are thought to have PSP, a prevalence matching that of ALS, the disease known as Lou Gehrig's disease. Parkinson's, by contrast, affects at least 500,000 Americans, making it far more common and far better understood.
Wexton's announcement came as part of a broader moment in American politics. Senator Dianne Feinstein, 90, had already declared she would not seek reelection following multiple medical episodes, including shingles and a public appearance in which she seemed confused during a Senate floor vote. Senator Mitch McConnell, 81, had experienced two episodes of freezing in front of reporters within weeks of each other but insisted he would remain in office and finish his term. Polls showed voters increasingly anxious about President Joe Biden's age—he was 80 and would be 86 if reelected and completed a second term. Against this backdrop, Wexton's decision to step aside carried weight beyond her own circumstances.
She had built a notable political career. The daughter of two economists, she had worked as a lawyer before running for the Virginia State Senate in 2013. In 2018, she won election to the U.S. House, defeating a sitting Republican and flipping Loudoun County—held by Republicans for four decades—to Democratic control. She cited the election of Donald Trump as a catalyst for that leap into federal office. She had been married for 22 years and had two sons.
In her announcement, Wexton did not soften the reality of her condition. "This new diagnosis is a tough one," she said. "There is no 'getting better' with PSP." The statement carried the weight of someone confronting a disease with no cure, no proven way to slow its course, and a trajectory measured in years rather than decades. Her decision to leave office was not a retreat but a recognition—that the demands of Congress, the travel, the late nights, the cognitive and physical stamina required, were incompatible with a condition that would only worsen. She would serve out her current term but would not run again.
Citações Notáveis
This new diagnosis is a tough one. There is no 'getting better' with PSP.— Rep. Jennifer Wexton
A Conversa do Hearth Outra perspectiva sobre a história
When she first got the Parkinson's diagnosis in April, she seemed to think she could manage it and stay in office. What changed between then and September?
The diagnosis itself changed. Doctors initially thought it was Parkinson's, which is manageable for many people—there are treatments that can slow it down. But PSP is a different animal entirely. It's rarer, more aggressive, and there's nothing that actually stops it.
So it wasn't just about accepting bad news. It was about getting worse news.
Exactly. And the worse news came with a timeline. Five to seven years. That's not abstract—that's a number that forces you to think about what you can and can't do with the time you have left.
Congress is demanding work. Long hours, travel, constant decision-making. How does a degenerative neurological disease interact with that?
PSP attacks speech, swallowing, balance, eye movement, cognition. Imagine trying to give a speech when your speech is deteriorating. Imagine voting when your balance is failing. She could have stayed and pushed through, but at what cost—to herself, to her ability to actually do the job?
There's something about the honesty of her statement—"There is no getting better with PSP." That's not political language.
No, it's the language of someone who has looked at the medical reality and decided to be clear about it. She didn't hedge. She didn't say she'd fight on. She said: this is what this is, and I'm making a choice based on that.
Does her stepping aside change anything about how we talk about aging and fitness in Congress?
It adds a voice to a conversation that was already happening—Feinstein, McConnell, Biden's age. But Wexton's case is different. She's not 80 or 90. She's 55. This isn't about age. It's about a disease that doesn't care how old you are.